Springtide, an autism treatment center network in Connecticut, completed a $18.1 million Series A round of equity financing led by Deerfield Management Company and Optum Ventures. Springtide provides evidence-based, family-centered, collaborative care at technology-enabled interdisciplinary clinics for children with autism spectrum disorder. Springtide has offices in Connecticut and New York, New York. The company plans to use funds from its Series A round to enhance its clinical operations and ensure quality of care as it expands into new markets. It will also focus on commercializing its technology platform for remote care extensions, data capture for automated reporting, and outcomes measurement and parent engagement.
Launched by Redesign Health, a health care innovation platform, Springtide works to improve the entire spectrum of care by offering fast and streamlined insurance eligibility and onboarding, data-driven lesson planning tools, automated data capture for outcomes reporting and measurement, and a telemedicine extension into the home and school. Springtide’s management team is comprised of senior leaders from Parsley Health, Cityblock Health, Oscar Health, and One Medical, including Springtide’s Chief Executive Officer, Jia Jia Ye, a former executive at One Medical and Oscar, where she played instrumental roles in scaling those organizations nationally.
Representatives from Deerfield and Optum Ventures will join Springtide’s board of directors. Deerfield invests across health care and has an extensive health care services and technology portfolio. Optum Ventures is the independent venture fund of Optum, a leading information and technology-enabled health services business dedicated to helping make the health system work better for everyone. Along with participating in the Series A round, Optum Ventures will provide strategic guidance and support from its vast network of health care and analytic assets.
This was reported by Springtide on November 12, 2020.